earnings

Pascal Soriot: AstraZeneca 'on track' to hit big $40B goal, capping years-long turnaround campaign
Endpoints
Thu, 02/10/22 - 10:42 am
AstraZeneca
earnings
vaccines
COVID-19
Pascal Soriot
Pharma CEOs
Pfizer’s $100bn question
EP Vantage
Thu, 02/10/22 - 10:14 am
Pfizer
COVID-19
earnings
GlaxoSmithKline's COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark
Fierce Pharma
Thu, 02/10/22 - 10:11 am
GSK
earnings
COVID-19
Vir Biotchnology
Teva execs claim mixed winning streak in pricey opioids court battle — as permanent peace remains elusive
Endpoints
Wed, 02/9/22 - 10:57 pm
Teva Pharmaceutical
earnings
Kåre Schultz
legal
opioids
Robots cushion omicron's blow to Q4 orthopaedic device sales
Medtech Dive
Wed, 02/9/22 - 10:04 am
Medtech
devices
earnings
Zimmer Biomet
Stryker
JNJ
COVID-19
robotic surgery
Amgen talks long-term growth, but doubts remain for analysts, investors
Fierce Pharma
Tue, 02/8/22 - 11:54 pm
Amgen
earnings
COVID-19 treatments earned 4 drugmakers $14B in 2021
Beckers Hospital Review
Tue, 02/8/22 - 11:50 pm
Eli Lilly
Gilead Sciences
Merck
Regeneron
COVID-19
earnings
Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B
Endpoints
Tue, 02/8/22 - 10:12 am
Pfizer
COVID-19
vaccines
drug sales
earnings
Why Shares of PerkinElmer Dropped 14.4% in January
Motley Fool
Mon, 02/7/22 - 10:12 am
PerkinElmer
earnings
diagnostics
Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
Fierce Pharma
Fri, 02/4/22 - 01:06 pm
Sanofi
Dupixent
earnings
COVID-19
Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales
Yahoo/Zacks.com
Thu, 02/3/22 - 11:41 pm
earnings
Eli Lilly
Roche regains pre-pandemic sales footing, highlights bursting pipeline — with one key failure
Endpoints
Thu, 02/3/22 - 11:09 pm
Roche
earnings
pandemic
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year
Fierce Pharma
Thu, 02/3/22 - 11:45 am
Biogen
earnings
Aduhelm
Alzheimer's disease
AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat
Fierce Pharma
Wed, 02/2/22 - 11:50 pm
AbbVie
earnings
Restasis
FDA
generics
Omicron Delivers Blow to Boston Sci’s Guidance
Medical Devices and Diagnostics Industry
Wed, 02/2/22 - 11:48 pm
devices
earnings
Boston Scientific
COVID-19
pandemic
AbbVie's Gonzalez: Skyrizi and Rinvoq to become Humira 2.0 — while adding an indication for atopic dermatitis
Endpoints
Wed, 02/2/22 - 11:46 pm
AbbVie
earnings
Rick Gonzalez
Skyrizi
Rinvoq
Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing
NASDAQ
Wed, 02/2/22 - 11:44 pm
Novartis
earnings
Sandoz
Here's What to Know About Vertex Pharmaceuticals' Earnings Report
Motley Fool
Tue, 02/1/22 - 10:31 am
Vertex Pharmaceuticals
earnings
Omicron Strikes Stryker, But Mako Saves the Day
Medical Devices and Diagnostics Industry
Mon, 01/31/22 - 11:56 pm
devices
Stryker
earnings
pandemic
COVID-19
Mako Surgical
Edwards sees hospital capacity slow TAVR procedures, keeps 2022 guidance
Medtech Dive
Fri, 01/28/22 - 10:19 am
devices
Medtech
Edwards Lifesciences
TAVR
earnings

Pages